<DOC>
	<DOCNO>NCT02116855</DOCNO>
	<brief_summary>A multi centre two year long term escalate dose tertiary prophylaxis study efficacy cost save individualize low dose prophylaxis regimens boy severe hemophilia A China star low dose regimen step I , escalate low dose regimen step II tailor dose regimen base individual PK profile step III . The dose escalation criterion adjust accord pattern frequency joint bleed assess subject every 3 month . Efficacy 3 different dose regimen measure Annualized Joint Bleeding rate ( AJBR ) primary end point Hemophilia Joint Health Score ( HJHS ) QoL score ( CHO-KLAT PedsQoL ) , image study target joint Ultrasound , X-ray MRI examination , consumption factor VIII inhibitor rate secondary end point .</brief_summary>
	<brief_title>Individualized Prophylaxis Severe Hemophilia A Children</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>1 . Severe hemophilia A FVIII &lt; 1 % 2 . Age 6 10 year 3 . Patients 50 exposure day ( ED ) 4 . Patients one target joint ( target joint define joint 3 bleeds consecutive 3 month ) disease joint ( define presence visible joint swell /or limitation movement and/or joint deformity absent acute joint bleed ) 5. ondemand treatment 12months study 1 . A history FVIII inhibitor ( titer great 0.6 BU ) detectable FVIII inhibitor screening ( titer great 0.6 BU ) 2 . Chronic renal failure ( serum creatinine great 2.0 mg /dL ) 3 . Chronic Liver disease ( ALT great 200 U/L ) ) 4 . Patients clinically document immunodeficiency 5 . Patients anticipate require Major surgery 6 . Patients compete high risk symptomatic HIV infection , Juvenile rheumatoid arthritis , metabolic bone disease , disease know mimic cause joint diseases 7 . Patients live far comprehensive care centre BCH demonstrate previous non compliance therapy clinical study</criteria>
	<gender>Male</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>